Next Step: Upper Endoscopy (EGD)
The next step in investigating postprandial abdominal pain with negative H. pylori and celiac testing, especially when GERD medications are not tolerated, is to perform upper endoscopy (esophagogastroduodenoscopy) to exclude structural pathology and confirm functional dyspepsia. 1
Clinical Reasoning
Your patient presents with postprandial abdominal pain and has already had appropriate initial testing (H. pylori and celiac disease excluded). The inability to tolerate GERD medication is a critical factor that changes the typical management pathway.
Why Endoscopy Now?
The 2022 British Society of Gastroenterology guidelines on functional dyspepsia clearly state that referral for endoscopy is required when:
- Patients are older at symptom onset
- There is a family history of esophageal or gastric cancer
- Initial medical management fails or cannot be tolerated 1
Your patient falls into the third category—they cannot tolerate standard acid suppression therapy, which represents a failure of the typical empiric treatment approach.
What the Endoscopy Should Include
If endoscopy shows normal-appearing mucosa, the 2015 AGA guidelines recommend specific biopsy protocols 2:
For gastric biopsies (if not already H. pylori tested endoscopically):
- Use the updated Sydney System protocol: specimens from lesser and greater curve of antrum (within 2-3 cm of pylorus), lesser curvature of corpus (4 cm proximal to angularis), middle portion of greater curvature of corpus (8 cm from cardia), and one from incisura angularis
- This identifies 100% of H. pylori infections that might have been missed on non-invasive testing
For duodenal biopsies:
- The AGA suggests not routinely biopsying normal-appearing duodenum solely for celiac disease when serologic testing is already negative and there are no other risk factors 2
- However, if there are any visual abnormalities or high clinical suspicion despite negative serology, biopsies remain appropriate
After Endoscopy: Managing Functional Dyspepsia
If endoscopy is normal (confirming functional dyspepsia), the treatment pathway shifts since acid suppression is not tolerated 1:
Alternative pharmacologic options:
- Neuromodulators (low-dose tricyclic antidepressants like amitriptyline 10-25 mg at bedtime) - these work on gut-brain axis sensitivity rather than acid suppression
- Prokinetics (if available in your region) - help with gastric emptying and early satiety
- Histamine receptor antagonists or mast cell stabilizers - emerging evidence suggests these may help with food-triggered symptoms 3
Non-pharmacologic approaches:
- Lifestyle modifications: regular exercise, identifying and avoiding specific food triggers
- Psychological/behavioral therapies - cognitive behavioral therapy or gut-directed hypnotherapy have evidence for benefit 1
- Dietary modifications: Consider trial of low FODMAP diet, though avoid overly restrictive diets that risk malnutrition 1, 3
Important Caveats
Do not skip endoscopy in this scenario. While the yield for serious pathology remains low even with investigation 1, the inability to use standard medical therapy means you need definitive confirmation that no structural disease exists before committing to long-term functional dyspepsia management.
The postprandial nature of symptoms matters. Recent research suggests postprandial symptoms may arise from food antigen-driven immune responses with eosinophil and mast cell activation 3. This mechanistic understanding supports why antihistaminic medications (including certain tricyclic antidepressants) may be particularly effective when acid suppression fails.
Age and alarm features remain critical. If your patient is over 55 years or has any alarm features (unintentional weight loss, progressive dysphagia, persistent vomiting, evidence of GI bleeding, palpable mass, iron deficiency anemia), endoscopy becomes even more urgent 1, 4.